The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: A view from tropical and subtropical Africa

Gut

Volumn 38, Issue SUPPL. 2, 1996, Pages

  Kiire, C F ^a,b  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

^b SOUTHPORT AND ORMSKIRK HOSPITAL NHS TRUST   (United Kingdom)

Author keywords

hepatitis B; horizontal transmission; immunisation; sub Saharan Africa

Indexed keywords

HEPATITIS B VACCINE;

AFRICA; CONFERENCE PAPER; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INFECTION CONTROL; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0029936113     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.suppl_2.s5     Document Type: Conference Paper

References (44)

1. WHO Technical Advisory Group on Viral Hepatitis. Progress in the control of viral hepatitis; memorandum from a WHO Meeting. Bull World Health Organ 1988; 4: 443-55.
2. Maynard JH, Kane MA, Alter HJ, Hadler SC. Control of hepatitis B by immunization: global perspectives. In: Zuckerman AJ, ed. Viral hepatitis and liver diseases. New York: Alan R Liss, 1988: 967-9.
3. Maynard JH, Kane MA, Hadler SC. Global control of hepatitis B through immunization: role of hepatitis B vaccine in the Expanded Programme on Immunization. Rev Infect Dis 1989; 11 (suppl 3): 574-88.
4. World Health Organisation. Prevention of liver cancer. Report of a WHO Meeting. WHO Tech Rep Ser 1983; 691: 8-9.
5. Kiire CF and the African Regional Study Group. Hepatitis B in sub-Saharan Africa. In: Blumberg BS, Hepburn A, Andre FE, eds. Proceedings of International Conference on Prospects for Eradication of the Hepatitis B Virus. Vaccine 1990; 8 (suppl): 107-12.
6. Whittle HC, Bradley AK, McLaughlan K, et al. Hepatitis B in two Gambian villages. Lancet 1983; i: 1203-6.
7. Hall AJ, Inskip HM, Loik F, et al. The Gambian Hepatitis B Intervention Study. International Agency for Research on Cancer. Annual Report, 1988: 1-152.
8. Prince AM, White T, Pollock N, Riddle J, Brotman B, Richardson L. Epidemiology of hepatitis B infection in Liberian infants. Infect Immunol 1981; 32: 675-80.
9. Neppert J, Gerlich W. Studies on the serological manifestation of the hepatitis B virus in the Republic of Liberia (author's translation). Zentralbl Bakteriol 1979; 245: 8-16.
10. Maupas P, Chiron JP, Goudeau A, et al. Epidemiology and pathologic results of chronic carrier state of hepatitis B in Mali. Bull Soc Pathol Exot Filiates 1981; 74: 722-32.
11. Szmuness W, Prince AM, Diebolt G, et al. The epidemiology of hepatitis B infection in Africa: results of a pilot survey in the Republic of Senegal. Am J Epidemiol 1973; 98: 843-9.
12. Barin F, Perrin J, Chotard J, et al. Cross-sectional longitudinal epidemiology of hepatitis B in Senegal. Prog Med Viral 1981; 27: 148-67.
13. Coursaget P, Yvonnet B, Chotard J, et al. Age and sex-related study of hepatitis B in infants from an endemic area (Senegal). J Med Virol 1987; 22: 1-5.
14. Tabor E, Bayley AC, Cairns L, Gerety RL. Horizontal transmission of hepatitis B virus among children and adults in five rural villages in Zambia. J Med Virol 1985; 15: 113-20.
15. Prozesky OW, Szmuness W, Stevens CE, et al. Baseline epidemiological studies for a hepatitis B vaccine trial in KaNgwane. S Afr Med J 1983; 64: 891-3.
16. Botha JF, Ritchie MJJ, Dusheiko GM, Mouton HWK, Kew MC. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet 1984; i: 1210-2.
17. DiBisceglie AM, Kew MC, Dusheiko GM, et al. Prevalence of hepatitis B virus among black children in Soweto. BMJ 1986; 292: 1440-2.
18. Baghshawe A, Nganda TN. Hepatitis B antigen in a rural community in Kenya. Trans R Soc Trop Med Hyg 1973; 67: 663-7.
19. Bowry TR. The pattern of transmission of hepatitis B in an urban population of Kenya. J Med Virol 1984; 64: 385-91.
20. Hyams KC, Okoth FC, Tukei PM, et al. Epidemiology of hepatitis B in Eastern Kenya. J Med Virol 1989; 28: 106-9.
21. Tsega E, Mengesha B, Nordenfelt E, Hansson B, Lindberg J. Prevalence of hepatitis B virus markers among Ethiopian blood donors: Is HBsAg necessary? Trop Geogr Med 1987; 39: 336-40.
22. Tsega E, Mengesha B, Hansson B, Lindberg J, Nordenfelt E. Hepatitis A, B and delta infection in Ethiopia: A serologic survey with demographic data. Am J Epidemiol 1986; 123: 344-51.
23. Tsega E, Tsega M, Mengesha B, Nordenfelt E, Hansson B, Lindberg J. Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission. Int J Epidemiol 1988; 17: 874-9.
24. Kiire CF. Hepatitis B virus carrier state among black children in Zimbabwe. MD Thesis. Kampala, Makerere University, 1990: 1-90.
25. Ghendon Y. Perinatal transmission of hepatitis B in high incidence countries. J Virol Methods 1987; 17: 67-79.
26. Basalamah AH, Serebour F, Kazim E. Materno-foetal transmission of hepatitis B in Saudi Arabia. J Infect 1984; 8: 200-4.
27. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immunoglobulin for prevention of perinatal transmission of the HBV carrier state. Final report of a randomised double blind placebo-controlled trial. Hepatology 1983; 3: 135-41.
28. Korba BE, Well F, Tennant BC, Yoakum GH, Purell RH, Gerin JL. Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis. J Virol 1986; 58: 1-8.
29. Barin F, Goudeau A, Denis F, et al. Immune response in neonates to hepatitis B vaccine. Lancet 1982; i: 251-3.
30. Cancio-Bello TP, de Medina M, Shorey J, Valledor MD, Schiff ER. An institutional outbreak of hepatitis B related to a human biting carrier. J Infect Dis 1982; 146: 652-6.
31. Prozesky OW, Stevens CE, Szmuness W, et al. Immune response to hepatitis B vaccine in newborns. J Infect 1983; 7 (suppl 1): 53.
32. Barin F, Yvonnet B, Goudeau A, et al. Hepatitis B vaccine: further studies in children with previously acquired hepatitis B surface antigenemia. Infect Immunity 1983; 41: 83-7.
33. Coursaget P, Chiron JP, Yvonnet B, et al. Hepatitis B immunization in pregnancy: maternal immune response and transmission of anti-HBs antibodies to infants. Int J Microbiol 1983; 1: 27-34.
34. Coursaget P, Chiron JP, Yvonnet B, et al. Simultaneous administration of hepatitis B and diphtheria/tetanus/polio vaccines. Lancet 1984; i: 623-4.
35. Yvonnet B, Coursaget P, Deubel V, Diop Mar I, Digoutte JP, Chiron JP. Simultaneous administration of hepatitis B, yellow fever vaccines. 19th IABS Congress on Use and Standardization of Combined Vaccine. Dev Biol Standard 1985; 65: 205-7.
36. Yvonnet B, Coursaget P, Leboullex D, et al. Low dose hepatitis B immunization in children. Lancet 1987; i: 169.
37. Yvonnet B, Coursaget P, Petat E, et al. Immunologic effect of hepatitis B vaccine in children; comparison of two or three dose protocol. J Med Virol 1984; 14: 137-49.
38. Ayoola EA, Atoba MA, Johnson CA. Intradermal vaccination against hepatitis B infection in an endemic area (Nigeria), two year results. Arch Virol 1986; 91: 291-6.
39. Coursaget P, Yvonnet B, Chiron JP, Diop Mar I. Long term efficacy of hepatitis B vaccine in infants from an endemic area. Ann Virol 1986; 137E: 221-4.
40. Yvonnet B, Coursaget P, Chotard J, et al. Hepatitis B vaccine in infants from an endemic area: long term anti-HBs persistence and revaccination. J Med Virol 1987; 22: 315-21.
41. Coursaget P, Yvonnet B, Chotard J, et al. Seven year study of hepatitis B efficacy in infants from an endemic area. Lancet 1986; i: 1143-5.
42. Hall AJ, Inskip HM, Loik FM, et al. The Gambia Hepatitis Intervention Study. Annual Report. The International Agency for Research on Cancer, Lyon, 1989: 12-4.
43. The International Task Force on Hepatitis B Immunization. Notes on hepatitis B and its control. Program for Appropriate Technology in Health (PATH), Seattle, 1988: 1-6.
44. Waterhouse J, Muir C, Powell J, eds. Cancer incidence in five comments. Lyon: WHO, 1977: 122-3.